CSM segment going from strength to strength!
CSM segment going from strength to strength! PI's FY21 Annual Report highlights its intention to build multiple growth engines and take PI to the...
242 Views
PI Industries: Growth Remains Intact with Foray into Pharma Segment
We value PIIND at 36x (PE its FY24E EPS) given the strong performance on the export and domestic front and wait for more clarity on ramping up of...
119 Views
PI Industries: Next Growth Phase to Emanate from Pharma
Gross margins improved 180 bps YoY to ~43.8% while EBITDA margin contracted 80 bps YoY to 20.8%, due to higher employee (up 20% YoY) and other...
103 Views
Broadening its horizon with API acquisition
Earning below estimates, but strong show on high base PI Industries (PI)'s operating performance during the quarter was impacted by one-time...
143 Views